Bancroft becomes permanent CFO at Bristol-Myers

Kaitlyn Dmyterko | April 09, 2010 | Cardiovascular Business | Structural Heart Disease

Bristol-Myers Squibb (BMS) has selected Charles Bancroft to serve as its permanent chief financial officer (CFO).

According to the New York City-based company, Bancroft has operated as the company’s acting CFO since Jan. 1, but the appointment became official April 8.

Bancroft will oversee the company’s fiscal operations and global finance organization and report to Lamberto Andreotti, the company’s president, chief operating officer and acting CEO.

Prior to his selection as CFO, Bancroft carried out international assignments and leadership positions with BMS and also ConvaTec. BMS said that Bancroft began employment with the company in 1984.

Kaitlyn Dmyterko

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Bancroft becomes permanent CFO at Bristol-Myers

Related Content

Around the web